VA Salt Lake City Health Care System
Welcome,         Profile    Billing    Logout  
 16 Trials 
13 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stehlik, Josef
NCT05420012: The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

Completed
4
26
US
Vericiguat, VERQUVO, Placebo, Control group
Josef Stehlik, Merck Sharp & Dohme LLC
Heart Failure, Heart Failure with Reduced Ejection Fraction (HFrEF)
10/24
10/24
NCT03644667: Tocilizumab in Cardiac Transplantation

Active, not recruiting
2
385
US
tocilizumab, Actemra®, Placebo, Placebo for tocilizumab, Placebo for Actemra®, Standard of Care Triple IS, calcineurin inhibitor: (tacrolimus (Prograf ®)), anti-proliferative treatment: (mycophenolate mofetil ),, MMF, CellCept®, Myfortic®, enteric-coated mycophenolate sodium, steroids: methylprednisolone/prednisone
National Institute of Allergy and Infectious Diseases (NIAID), PPD
Heart Transplant
04/25
04/25
DETECT, NCT05081739: Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation

Withdrawn
N/A
600
NA
Prospera Transplant Assessment, Endomyocardial biopsy
Natera, Inc.
Heart Transplant Failure and Rejection
01/25
01/26
ACES-EMB, NCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

Recruiting
N/A
250
US
The Prospera™ Test
Natera, Inc.
Heart Transplant Failure and Rejection
12/24
12/25
NCT04707872: Trifecta-Heart cfDNA-MMDx Study

Recruiting
N/A
300
Europe, Canada, US, RoW
MMDx diagnostic test, Prospera, HLA antibody
University of Alberta, Natera, Inc., One Lambda
Heart Transplant Rejection
12/26
07/27
DEFINE-HT, NCT05309382: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Completed
N/A
147
US
Prospera
Natera, Inc.
Heart Transplant
10/24
10/24
Drakos, Stavros
NCT04977310: TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care

Withdrawn
N/A
10
US
CardioMEMS
STAVROS G DRAKOS, Abbott
Heart Failure
09/26
09/26
Rhoads, Jamie
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting
3
595
Europe, Canada, Japan, US, RoW
Baricitinib, LY3009104, Placebo
Eli Lilly and Company
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical
09/24
08/29
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Recruiting
2/3
120
US
Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline
Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC
Warts
12/25
12/26
AMETHYST, NCT05531565 / 2020-000727-40: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Recruiting
2/3
474
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen, Biogen Idec Research Limited
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
10/26
12/27
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Klein, Stephanie Z
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Recruiting
2/3
120
US
Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline
Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC
Warts
12/25
12/26
Nicholson, Lowell
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Recruiting
2/3
120
US
Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline
Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC
Warts
12/25
12/26

Download Options